Cardiac Rhythm Management

Patients

CRM Group The CRM group focuses on developing the most advanced implantable devices to help treat a number of cardiac conditions.

Pacemakers treat people with bradyarrhythmias, or slow heart rhythms. Pacemakers can help relieve symptoms such as fatigue.

Implantable cardioverter defibrillators (ICDs) treat tachyarrhythmias, or fast heart rhythms. Tachyarrhythmias in the ventricles can be life threatening. So ICDs can not only stop a fast rhythm and restore a normal heart rate, they can also help prevent sudden cardiac death.

Cardiac resynchronization therapy (CRT) devices help resynchronize the ventricles—allowing both sides of the heart to beat in a coordinated way. CRT devices can relieve patients' symptoms of heart failure such as fatigue and shortness of breath.

All of these therapies can improve patients' quality of life.

The Boston Scientific CRM group has a distinguished track record. The CRM group not only introduced the world's first ICD, it also pioneered the research that led to CRT devices.

Today we continue this proud tradition of innovation. We remain committed to developing ever-improving technology. And in that way we secure Boston Scientific's role as a leader in the industry.